Gadoterate Meglumine Injectable Solution

Gadoterate Meglumine Injectable Solution

Form: Injectable Solution

Strength: 0.5 mol/L

Reference Brands: Dotarem(US & EU)

Category: Contrast Agent

Gadoterate meglumine, marketed as Dotarem, is approved in the US by the FDA and in the EU via EMA for MRI diagnostics of brain, spinal cord, and joints. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety profiles, manufacturing standards, and pharmacovigilance plans. The FDA reviews detailed clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper regional adherence supports swift approval, safe administration, and global availability, assisting healthcare providers worldwide in delivering high-quality diagnostic imaging.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Sulfur Hexafluoride Microbubbles injection

Strength: 60.7mg

Form: injection

Reference Brands: SonoVue(EU)

View Details Get Enquiry
Barium Sulfate Suspension

Strength: 30% w/v , 40% w/v

Form: Powder for oral suspension

Reference Brands: Gastroview, Osmo-Maq, FlexiView(US)

View Details Get Enquiry
Gadoxetate Injectable Solution

Strength: 0.25 mmol/mL

Form: Injectable Solution

Reference Brands: Eovist(US)

View Details Get Enquiry
Gadofosveset Injectable solution

Strength: 0.03 mmol/kg

Form: Injectable Solution

Reference Brands: Ablivar(US & EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.